Atrion Corporation (ATRI)
NASDAQ: ATRI · IEX Real-Time Price · USD
395.01
-3.96 (-0.99%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Atrion Revenue
In the year 2023, Atrion had annual revenue of $169.33M, a decrease of -7.73%. Revenue in the quarter ending December 31, 2023 was $43.58M with 1.70% year-over-year growth.
Revenue (ttm)
$169.33M
Revenue Growth
-7.73%
P/S Ratio
4.11
Revenue / Employee
$237,817
Employees
712
Market Cap
695.20M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 169.33M | -14.18M | -7.73% |
Dec 31, 2022 | 183.51M | 18.50M | 11.21% |
Dec 31, 2021 | 165.01M | 17.42M | 11.80% |
Dec 31, 2020 | 147.59M | -7.48M | -4.82% |
Dec 31, 2019 | 155.07M | 2.62M | 1.72% |
Dec 31, 2018 | 152.45M | 5.85M | 3.99% |
Dec 31, 2017 | 146.60M | 3.11M | 2.17% |
Dec 31, 2016 | 143.49M | -2.25M | -1.54% |
Dec 31, 2015 | 145.73M | 4.97M | 3.53% |
Dec 31, 2014 | 140.76M | 8.77M | 6.64% |
Dec 31, 2013 | 131.99M | 12.93M | 10.86% |
Dec 31, 2012 | 119.06M | 1.36M | 1.15% |
Dec 31, 2011 | 117.70M | 9.14M | 8.41% |
Dec 31, 2010 | 108.57M | 7.93M | 7.88% |
Dec 31, 2009 | 100.64M | 4.75M | 4.95% |
Dec 31, 2008 | 95.90M | 7.36M | 8.31% |
Dec 31, 2007 | 88.54M | 7.52M | 9.28% |
Dec 31, 2006 | 81.02M | 8.93M | 12.39% |
Dec 31, 2005 | 72.09M | 6.01M | 9.09% |
Dec 31, 2004 | 66.08M | 3.28M | 5.22% |
Dec 31, 2003 | 62.80M | 3.27M | 5.49% |
Dec 31, 2002 | 59.53M | 1.93M | 3.35% |
Dec 31, 2001 | 57.61M | 6.16M | 11.97% |
Dec 31, 2000 | 51.45M | 1.53M | 3.07% |
Dec 31, 1999 | 49.92M | 6.52M | 15.02% |
Dec 31, 1998 | 43.40M | 13.12M | 43.33% |
Dec 31, 1997 | 30.28M | 8.16M | 36.87% |
Dec 31, 1996 | 22.12M | 10.40M | 88.76% |
Dec 31, 1995 | 11.72M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pediatrix Medical Group | 1.99B |
Accolade | 388.49M |
HealthStream | 279.06M |
Cytek Biosciences | 193.02M |
OrthoPediatrics | 148.73M |
BioLife Solutions | 143.27M |
PureTech Health | 15.62M |
Autolus Therapeutics | 1.70M |
ATRI News
- 2 months ago - Atrion Reports Fourth Quarter And Full Year 2023 Results - GlobeNewsWire
- 2 months ago - Atrion Corporation Declares Quarterly Cash Dividend - GlobeNewsWire
- 6 months ago - Atrion Reports Third Quarter 2023 Results - GlobeNewsWire
- 7 months ago - Atrion Corporation Announces Election of New Director - GlobeNewsWire
- 8 months ago - Atrion Corporation Increases Quarterly Cash Dividend - GlobeNewsWire
- 9 months ago - Atrion Reports Second Quarter 2023 Results - GlobeNewsWire
- 9 months ago - Atrion Corp (ATRI): A Medical Device Stock with Good Outperformance Potential - GuruFocus
- 1 year ago - Atrion Reports First Quarter 2023 Results - GlobeNewsWire